Background Irritable bowel syndrome is a widespread disorder with a marked
socioeconomic burden. Previous studies support the proposal that a subset of patients with …

Irritable bowel syndrome (IBS) is a chronic and relapsing functional gastrointestinal disorder
that affects 9-23% of the population across the world. Patients with IBS are often referred to …

Functional gastrointestinal disorders (FGIDs), the most common diagnoses in
gastroenterology, are recognized by morphologic and physiological abnormalities that often …

Every May, Gastroenterology publishes a supplemen-tary issue devoted to a topic of
particular interest to the science and practice of gastroenterology. Through a collaboration …

Background In Europe, IBS is commonly treated with musculotropic spasmolytics (eg,
otilonium bromide, OB). In tertiary care, a low fermentable oligosaccharides, disaccharides …

Background Gut‐focused hypnotherapy improves the symptoms of irritable bowel syndrome
(IBS) with benefits being sustained for many years. Despite this, the technique has not been …

Objectives Previous studies have found a high prevalence of irritable bowel syndrome (IBS).
However, data on this relation in women without bowel endometriosis is limited. The aim of …

Background: Irritable bowel syndrome (IBS) reduces health-related quality of life (HRQOL). It
is unclear how having IBS modifies the impact of gastrointestinal (GI), psychosocial, and …

Background Despite the epidemiological and economic relevance of the irritable bowel
syndrome (IBS), there is a lack of research on what the general public knows and thinks …

Irritable bowel syndrome is a functional bowel disorder with gastrointestinal symptoms (eg
abdominal pain, straining, urgency, incomplete evacuation, nausea, and bloating) that occur …